质粒介导的tet(A)突变体对肺炎克雷伯氏菌替加环素耐药的影响

doi:10.3969/j.issn.1004-1524.2018.05.07

浙江农业学报 ›› 2018, Vol. 30 ›› Issue (5): 717-721.DOI: 10.3969/j.issn.1004-1524.2018.05.07

质粒介导的tet(A)突变体对肺炎克雷伯氏菌替加环素耐药的影响

荆炜, 程于梦, 单新新, 李德喜, 姚红, 杜向党^*

河南农业大学牧医工程学院, 河南郑州 450046

收稿日期:2018-01-31 出版日期:2018-05-20 发布日期:2018-05-23
通讯作者: 杜向党,E-mail: ,xddu@henau.edu.cn
作者简介:荆炜(1993—),女,河南漯河人,硕士,主要从事细菌耐药性研究。E-mail: m17719108272@163.com
基金资助:
河南省高校科技创新团队支持计划(18IRTSTHN020)

Effect of plasmid-mediated tet(A) variant on tigecycline resistance in Klebsiella pneumoniae

JING Wei, CHENG Yumeng, SHAN Xinxin, LI Dexi, YAO Hong, DU Xiangdang^*

College of Animal Science and Veterinary Medicine, Henan Agricultural University, Zhengzhou 450046, China

Received:2018-01-31 Online:2018-05-20 Published:2018-05-23

摘要/Abstract

摘要： 替加环素是治疗多重耐药肺炎克雷伯氏菌感染的为数不多的抗菌药物之一,但替加环素耐药肺炎克雷伯氏菌的出现给临床治疗带来了严重威胁。本实验从临床分离到1株替加环素耐药肺炎克雷伯氏菌,电转化实验获得了一个对替加环素耐药的质粒,功能性分析发现该质粒中的tet(A)基因发生了双移码突变,且药敏实验证实这些突变可单独使替加环素的MIC值增加8倍,米诺环素和四环素的MIC值增加128倍。研究证实,质粒介导的tet(A)突变体可导致肺炎克雷伯氏菌对替加环素耐药,扩宽了对肺炎克雷伯氏菌替加环素耐药机制的认识,并为该类型耐药基因在革兰氏阴性菌中的扩散控制提供了依据。

关键词: 替加环素, 肺炎克雷伯氏菌, tet(A)突变, 耐药机制

Abstract: Tigecycline is one of the last choices to treat multidrug-resistant Klebsiella pneumoniae infection. However, the emergence of the tigecycline-resistant Klebsiella pneumoniae has posed a serious threat in clinical treatment. A clinical tigecycline-resistant Klebsiella pneumoniae strain was isolated, and a tigecycline-resistant plasmid was obtained by electroporation. Functional analysis revealed that two frameshift mutations occurred in the tet(A) gene on this plasmid. The antimicobial susceptibility tests indicated that the mutations could increase the minimal inhibition concentrations of tigecycline by 8 folds, whlie the MIC values of minocycline and tetracycline could increase 128 times due to these point mutations. The study confirmed that the plasmid-mediated tet(A) variant could confer the resistance to tigcycline in Klebsiella pneumoniae, which not only broaded the theoretical understanding about the resistance mechanism of Klebsiella pneumoniae to tigecycline, but also provided a basis to control the spread of such resistant gene among the gram-negative organisms.

Key words: tigecycline, Klebsiella pneumoniae, tet(A) mutation, resistance mechanism

中图分类号:

荆炜, 程于梦, 单新新, 李德喜, 姚红, 杜向党. 质粒介导的tet(A)突变体对肺炎克雷伯氏菌替加环素耐药的影响[J]. 浙江农业学报, 2018, 30(5): 717-721.

JING Wei, CHENG Yumeng, SHAN Xinxin, LI Dexi, YAO Hong, DU Xiangdang. Effect of plasmid-mediated tet(A) variant on tigecycline resistance in Klebsiella pneumoniae[J]. , 2018, 30(5): 717-721.

参考文献

[1] PENDLETON J N, GORMAN S P, GILMORE B F.Clinical relevance of the ESKAPE pathogens[J]. Expert Review of Anti-infective Therapy, 2013, 11(3):297-308.
[2] 康燕菲,田平芳,谭天伟. 肺炎克雷伯氏菌毒力因子的研究进展[J]. 微生物学报,2015,55(10):1245-1252.
KANG Y F, TIAN P F, TAN T W.Research progress on virulence factor of Klebsiella pneumonia[J]. Journal of Microbiology, 2015, 55(10):1245-1252. (in Chinese with English abstract)
[3] 孙桂凤,陈頔,孙钊. 新一代抗菌药物替加环素的研究进展[J]. 药品评价,2014(12):21-23.
SUN G F, CHEN Y, SUN Z.Progress in the research of tigecycline, a new generation of antibacterials[J]. Drug Evaluation, 2014(12):21-23. (in Chinese with English abstract)
[4] European Committee on Antimicrobial Susceptibility Testing (EUCAST) Steering Committee. EUCAST technical note on tigecycline[J]. Clinical Microbiology & Infection, 2017, 12(11):1147-1149.
[5] 雷正瑜. 16S rDNA序列分析技术在微生物分类鉴定中的应用[J]. 湖北生态工程职业技术学院学报, 2006,4(1):4-7.
LEI Z Y.Application of 16S rDNA-sequential analysis in classification and determination of micro-organism[J]. Journal of Hubei Ecology Engineering College, 2006, 4(1):4-7. (in Chinese with English abstract)
[6] DOWER W J, MILLER J F, RAGSDALE C W.High efficiency transformation of E. coli by high voltage electroporation[J]. Nucleic Acids Research, 1988, 16(13):6127-6145.
[7] 朱森康,黄磊,李燕飞,等. 制备高效大肠杆菌电转化感受态细胞和电转化条件的研究[J]. 生物技术通报,2011(10):206-209.
ZHU S K, HUANG L, LI Y F, et al. Preparation of efficient electrotransformation comptent cell of Escherichia coli and condition of electrotransformation[J]. Biotechnology Bulletin, 2011(10):206-209. (in Chinese with English abstract)
[8] European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Dieases (ESCMID). Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution[J]. Clinical Microbiology & Infection, 2000, 6:509-515.
[9] 何建新,吴荣辉,金小珍,等. 替加环素、米诺环素、多黏菌素B对碳青霉烯类敏感性降低和不敏感肺炎克雷伯菌的体外抗菌活性[J]. 浙江医学,2015,37(21):1761-1763.
HE J X, WU R H, JIN X Z, et al.Effects of tigecycline minocycline and polymyxin B against Klebsiella pneumonia with decreased or no susceptibility to carbapenems in vitro[J]. Zhejiang Medical, 2015, 37(21):1761-1763. (in Chinese with English abstract)
[10] LIVERMORE D M.Tigecycline: what is it, and where should it be used?[J]. Journal of Antimicrobial Chemotherapy, 2005, 56(4):611-614.
[11] OLSON M W, RUZIN A, FEYFANT E, et al.Functional, biophysical, and structural bases for antibacterial activity of tigecycline[J]. Antimicrobial Agents & Chemotherapy, 2006, 50(6):2156-2166.
[12] VELEBA M, SCHNEIDERS T.Tigecycline resistance can occur independently of the ramA gene in Klebsiella pneumoniae[J]. Antimicrob Agents Chemother, 2012, 56(8):4466-4467.
[13] ZHONG X, XU H, CHEN D, et al.First emergence of acrAB and oqxAB mediated tigecycline resistance in clinical isolates of Klebsiella pneumoniae pre-dating the use of tigecycline in a Chinese hospital[J]. PLoS One, 2014, 9(12):e115185.
[14] He F, Fu Y, Chen Q, et al.Tigecycline susceptibility and the role of efflux pumps in tigecycline resistance in KPC-producing Klebsiella pneumoniae[J]. PLoS One, 2015, 10(3):e0119064.
[15] WANG X, CHEN H, ZHANG Y, et al.Genetic characterisation of clinical Klebsiella pneumoniae isolates with reduced susceptibility to tigecycline: role of the global regulator RamA and its local repressor RamR[J]. International Journal of Antimicrobial Agents, 2015, 45(6):635-640.
[16] LIN Y T, HUANG Y W, HUANG H H, et al.In vivo evolution of tigecycline-non-susceptible Klebsiella pneumoniae strains in patients: relationship between virulence and resistance[J]. International Journal of Antimicrobial Agents, 2016, 48(5):485-491.
[17] NIELSEN L E, SNESRUD E C, ONMUSLEONE F, et al.IS5 element integration, a novel mechanism for rapid in vivo emergence of tigecycline nonsusceptibility in Klebsiella pneumoniae[J]. Antimicrobial Agents & Chemotherapy, 2014, 58(10):6151-6156.
[18] HAWSER S P, BOUCHILLON S K, HACKEL M, et al.Trending 7 years of in vitro activity of tigecycline and comparators against Gram-positive and Gram-negative pathogens from the Asia-Pacific region: Tigecycline evaluation surveillance trial (TEST) 2004-2010[J]. International Journal of Antimicrobial Agents, 2012, 39(6):490-495.
[19] VILLA L, FEUDI C, FORTINI D, et al.Genomics of KPC-producing Klebsiella pneumoniae sequence type 512 clone highlights the role of RamR and ribosomal S10 protein mutations in conferring tigecycline resistance[J]. Antimicrobial Agents & Chemotherapy, 2014, 58(3):1707-1712.
[20] BEABOUT K, HAMMERSTROM T G, PEREZ A M, et al.The ribosomal S10 protein is a general target for decreased tigecycline susceptibility[J]. Antimicrobial Agents & Chemotherapy, 2015, 59(9):5561-5566.

质粒介导的tet(A)突变体对肺炎克雷伯氏菌替加环素耐药的影响

Effect of plasmid-mediated tet(A) variant on tigecycline resistance in Klebsiella pneumoniae

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 1

编辑推荐

Metrics

本文评价